Page last updated: 2024-10-23

aztreonam and Endocarditis

aztreonam has been researched along with Endocarditis in 1 studies

Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.

Endocarditis: Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alghoribi, MF1
Alqurashi, M1
Okdah, L1
Alalwan, B1
AlHebaishi, YS1
Almalki, A1
Alzayer, MA1
Alswaji, AA1
Doumith, M1
Barry, M1

Other Studies

1 other study available for aztreonam and Endocarditis

ArticleYear
Successful treatment of infective endocarditis due to pandrug-resistant Klebsiella pneumoniae with ceftazidime-avibactam and aztreonam.
    Scientific reports, 2021, 05-06, Volume: 11, Issue:1

    Topics: Adult; Azabicyclo Compounds; Aztreonam; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, B

2021